Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIAsk in your own words. Each question is answered independently.
Select a question to fill the editor, then ask it or make it your own.
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 5107 | 26027-38-3 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
Nonionic surfactant mixtures varying in the number of repeating ethoxy (oxy-1,2-ethanediyl) groups. They are used as detergents, emulsifiers, wetting agents, defoaming agents, etc. Nonoxynol-9, the compound with 9 repeating ethoxy groups, is a spermatocide, formulated primarily as a component of vaginal foams and creams.
|
None
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Dec. 10, 1963 | FDA | PERSONAL PRODS |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| MeSH PA | D003271 | Contraceptive Agents, Female |
| MeSH PA | D012102 | Reproductive Control Agents |
| MeSH PA | D013089 | Spermatocidal Agents |
| MeSH PA | D013501 | Surface-Active Agents |
| CHEBI has role | CHEBI:38828 | non-ionic surfactant |
| CHEBI has role | CHEBI:49323 | contraceptive drugs |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Contraception | indication | 13197004 |
None
None
None
None
None
None
| ID | Source |
|---|---|
| 4018924 | VANDF |
| 4021065 | VANDF |
| C0068943 | UMLSCUI |
| CHEBI:753440 | CHEBI |
| CHEMBL2108472 | ChEMBL_ID |
| 7700 | PUBCHEM_CID |
| CHEMBL1410 | ChEMBL_ID |
| DB06804 | DRUGBANK_ID |
| 53750 | RXNORM |
| 5185 | MMSL |
| 001328 | NDDF |
| 007492 | NDDF |
| 326454008 | SNOMEDCT_US |
| 397179004 | SNOMEDCT_US |
| D017137 | MESH_DESCRIPTOR_UI |
| 48Q180SH9T | UNII |
| 48Q180SH9T | INXIGHT DRUGS |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| ConceptrolOptions | HUMAN OTC DRUG LABEL | 1 | 34362-0300 | GEL | 4 g | VAGINAL | OTC monograph not final | 9 sections |
| Gynol IIExtra Strength | HUMAN OTC DRUG LABEL | 1 | 34362-0302 | GEL | 3 g | VAGINAL | OTC monograph not final | 9 sections |
| Today Vaginal Contraceptive | HUMAN OTC DRUG LABEL | 1 | 44376-100 | SPONGE | 1000 mg | VAGINAL | NDA | 16 sections |
| VCF CONTRACEPTIVE | HUMAN OTC DRUG LABEL | 1 | 52925-112 | FILM, SOLUBLE | 280 mg | VAGINAL | OTC monograph drug | 14 sections |
| VCF CONTRACEPTIVE | HUMAN OTC DRUG LABEL | 1 | 52925-312 | AEROSOL, FOAM | 125 mg | VAGINAL | OTC MONOGRAPH NOT FINAL | 14 sections |
| VCF CONTRACEPTIVE PRE-FILLED APPLICATORS | HUMAN OTC DRUG LABEL | 1 | 52925-512 | GEL, METERED | 4 g | VAGINAL | OTC monograph drug | 13 sections |